172 related articles for article (PubMed ID: 30928404)
1. KRT17 confers paclitaxel-induced resistance and migration to cervical cancer cells.
Li J; Chen Q; Deng Z; Chen X; Liu H; Tao Y; Wang X; Lin S; Liu N
Life Sci; 2019 May; 224():255-262. PubMed ID: 30928404
[TBL] [Abstract][Full Text] [Related]
2. Berberine modulates Keratin 17 to inhibit cervical cancer cell viability and metastasis.
Liu L; Sun L; Zheng J; Cui L
J Recept Signal Transduct Res; 2021 Dec; 41(6):521-531. PubMed ID: 33045871
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA MIR205HG regulates KRT17 and tumor processes in cervical cancer via interaction with SRSF1.
Dong M; Dong Z; Zhu X; Zhang Y; Song L
Exp Mol Pathol; 2019 Dec; 111():104322. PubMed ID: 31655037
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel inhibits the progression of cervical cancer by inhibiting autophagy via lncRNARP11-381N20.2.
Zou SH; Du X; Lin H; Wang PC; Li M
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3010-3017. PubMed ID: 29863245
[TBL] [Abstract][Full Text] [Related]
5. TMEM45A Affects Proliferation, Apoptosis, Epithelial-Mesenchymal Transition, Migration, Invasion and Cisplatin Resistance of HPV-Positive Cervical Cancer Cell Lines.
Liu Y; Liu L; Mou ZX
Biochem Genet; 2022 Feb; 60(1):173-190. PubMed ID: 34143331
[TBL] [Abstract][Full Text] [Related]
6. [S100A7 promotes the metastasis and epithelial-mesenchymal transition on HeLa and CaSki cells].
Tian T; Hua Z; Wang LZ; Wang XY; Chen HY; Liu ZH; Cui ZM
Zhonghua Fu Chan Ke Za Zhi; 2018 Feb; 53(2):99-105. PubMed ID: 29534378
[No Abstract] [Full Text] [Related]
7. Keratin 17 knockdown suppressed malignancy and cisplatin tolerance of bladder cancer cells, as well as the activation of AKT and ERK pathway.
Li C; Su H; Ruan C; Li X
Folia Histochem Cytobiol; 2021; 59(1):40-48. PubMed ID: 33577073
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus oncoproteins differentially modulate epithelial-mesenchymal transition in 5-FU-resistant cervical cancer cells.
Vishnoi K; Mahata S; Tyagi A; Pandey A; Verma G; Jadli M; Singh T; Singh SM; Bharti AC
Tumour Biol; 2016 Oct; 37(10):13137-13154. PubMed ID: 27449048
[TBL] [Abstract][Full Text] [Related]
9. FOXM1 Promotes Drug Resistance in Cervical Cancer Cells by Regulating ABCC5 Gene Transcription.
Hou Y; Dong Z; Zhong W; Yin L; Li X; Kuerban G; Huang H
Biomed Res Int; 2022; 2022():3032590. PubMed ID: 35141332
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of Frizzled-7 expression inhibits migration, invasion, and epithelial-mesenchymal transition of cervical cancer cell lines.
Deng B; Zhang S; Miao Y; Zhang Y; Wen F; Guo K
Med Oncol; 2015 Apr; 32(4):102. PubMed ID: 25740178
[TBL] [Abstract][Full Text] [Related]
11. SMAD3 inducing the transcription of  STYK1 to promote the EMT process and improve the tolerance of ovarian carcinoma cells to paclitaxel.
Shi Y; Zhang J; Liu M; Huang Y; Yin L
J Cell Biochem; 2019 Jun; 120(6):10796-10811. PubMed ID: 30701575
[TBL] [Abstract][Full Text] [Related]
12. [Bcl-2 associated athanogene 3 affects the epithelial-mesenchymal transition in human cervical cancer].
Wei L; Qin XP; Zhao XX; Wang W
Zhonghua Fu Chan Ke Za Zhi; 2017 Aug; 52(8):551-557. PubMed ID: 28851173
[No Abstract] [Full Text] [Related]
13. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.
Sathyanarayanan A; Chandrasekaran KS; Karunagaran D
Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466
[TBL] [Abstract][Full Text] [Related]
14. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.
Hu D; Zhou J; Wang F; Shi H; Li Y; Li B
Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of Ezrin inhibited migration and invasion of cervical cancer cells in vitro.
Xi M; Tang W
Int J Immunopathol Pharmacol; 2020; 34():2058738420930899. PubMed ID: 32674647
[TBL] [Abstract][Full Text] [Related]
16. Research on chemotherapy efficacy of twist gene on cervical cancer cells to paclitaxel.
Sun Z; Zhang D; Cui Y; Cheng L; Cao J; Wu X
Pak J Pharm Sci; 2014 Sep; 27(5 Suppl):1713-8. PubMed ID: 25262524
[TBL] [Abstract][Full Text] [Related]
17. LncRNA KB-1471A8.2 Overexpression Suppresses Cell Proliferation and Migration and Antagonizes the Paclitaxel Resistance of Ovarian Cancer Cells.
Zhang M; Liu S; Fu C; Wang X; Zhang M; Liu G; Dai C; Gong Z; Xu H; Fu Z; Xu P; Xu J; Jia X
Cancer Biother Radiopharm; 2019 Jun; 34(5):316-324. PubMed ID: 30892073
[No Abstract] [Full Text] [Related]
18. Clusterin confers paclitaxel resistance in cervical cancer.
Park DC; Yeo SG; Shin EY; Mok SC; Kim DH
Gynecol Oncol; 2006 Dec; 103(3):996-1000. PubMed ID: 16890274
[TBL] [Abstract][Full Text] [Related]
19. Keratin 17 Is Induced in Oral Cancer and Facilitates Tumor Growth.
Khanom R; Nguyen CT; Kayamori K; Zhao X; Morita K; Miki Y; Katsube K; Yamaguchi A; Sakamoto K
PLoS One; 2016; 11(8):e0161163. PubMed ID: 27512993
[TBL] [Abstract][Full Text] [Related]
20. LncRNA PVT1 epigenetically silences miR-195 and modulates EMT and chemoresistance in cervical cancer cells.
Shen CJ; Cheng YM; Wang CL
J Drug Target; 2017 Aug; 25(7):637-644. PubMed ID: 28296507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
